Frank Pallone actually said...
When the REMs program was put into place as part of the Food and Drug Administration Amendment Act of 2Congress contemplated and ultimately made it explicit that these safety protocols should not be use as a means to delay generic competition.
Context
Pallone highlights the intent of the REMs program to prevent delays in generic drug competition.
03/12/2019